Behavioral manifestations of movement disorders. Parkinson's and Huntington's disease.
Nearly every patient with a movement disorder has some type of behavioral dysfunction, whether it is personality change or intellectual impairment. Since these behaviors have confounding effects on the management of patients, it behooves clinicians to maintain awareness of the spectrum of mental changes in these diseases of the basal ganglia.
D000328:Adult; D000368:Aged; D003704:Dementia / Q000150:complications; D003863:Depression / Q000150:complications; D003866:Depressive Disorder / Q000134:cerebrospinal fluid / Q000150:complications; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006816:Huntington Disease / Q000150:complications / Q000523:psychology*; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D007360:Intelligence; D008734:Methoxyhydroxyphenylglycol / Q000134:cerebrospinal fluid; D008875:Middle Aged; D010300:Parkinson Disease / Q000134:cerebrospinal fluid / Q000150:complications / Q000523:psychology*; D010551:Personality
D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid; D006719:Homovanillic Acid